Key figures
Highlights
2021 Revenue
2,146.7 Million euros |
+17.9% organic growth in 2021 |
Revenue by Region in 2021
17% Asia-Pacific |
36% Americas |
47% EMEA |
In millions of euros | 2021 revenue | Contribution | Organic growth 2021/2020 | Organic growth 2021/2019 |
---|---|---|---|---|
Europe, Middle East and Africa | 1,014.5 | 47% | 17% | 19.5% |
Americas | 773.1 | 36% | 20% | 6% |
Asia-Pacific | 359.2 | 17% | 14.5% | -2% |
Full-Year Revenues | 2,146.7 | 100% | 17.9% | 10.4% |
Revenue by Audience in 2021
17% Doctors & Patients |
18% Citizens |
21% Clients & Employees |
44% Consumers |
In million of euros | 2021 revenue | Contribution | Organic growth 2021/2020 | Organic growth 2021/2019 |
---|---|---|---|---|
Consumers1 | 945.8 | 44% | 25% | 9% |
Clients and employees2 | 452.2 | 21% | 14% | -9% |
Citizens3 | 376.4 | 18% | 6% | 36.5% |
Doctors and patients4 | 372.3 | 17% | 18% | 23.5% |
Full-Year Revenues | 2,146.7 | 100% | 17,9% | 10.4% |
Breakdown of Service Lines by audience segment:
1- Brand Health Tracking, Creative Excellence, Innovation, Ipsos UU, Ipsos MMA, Market Strategy & Understanding, Observer (excl. public sector), Social Intelligence Analytics
2- Automotive & Mobility Development, Audience Measurement, Customer Experience, Channel Performance (including Retail Performance and Mystery Shopping), Media development
3- Public Affairs, Corporate Reputation
4- Pharma (quantitative and qualitative)
Summary consolidated financial statement
In million of euros | 2021 | 2020 |
---|---|---|
Revenue | 2,146.7 | 1,873.4 |
Gross profit | 1,389.3 | 1,180.5 |
Operating margin | 277.4 | 189,9 |
Adjusted net profit*, attributable to the Group | 209.2 | 129,6 |
Workforce as of 31 December | 18,257 | 16,644 |
*Adjusted net profit is calculated before (i) non-cash items related to IFRS 2 (share-based compensation), (ii) amortisation of acquisition-related intangible assets (client relations), (iii) the impact net of tax of other noncurrent income, (iv) expense and the non-monetary impact of changes in puts in other financial income and expenses, (v) deferred tax liabilities related to goodwill for which amortisation is deductible in some countries.
Financial statement
In million of euros | 2021 | 2020 |
---|---|---|
Total shareholders' equity | 1,342 | 1,122 |
Financial debt | 181 | 347 |
Free cash flow | 346 | 369 |
Net debt / EBITDA | x 0,5 | x 1.6 |
Net gearing | 13.4% | 30.9% |
Share capital and voting rights as at 31 December 2021
Number of shares | % | Number of voting rights | % | |
---|---|---|---|---|
DT & Partners | 4,406,988 | 9.92 | 8,813,976 | 17.82 |
Didier Truchot | 277,351 | 0.62 | 549,901 | 1.11 |
Public | 38,233,559 | 86.04 | 38,363,509 | 77.59 |
Employees | 970,635 | 2.19 | 1,718,590 | 3.48 |
Including FCPE and Group savings plan | 17,812 | 0.04 | 35,624 | 0.072 |
Treasury shares | 547,702 | 1.23 | 0 | 0.00% |
Of which liquidity agreement | 15,581 | 0.04 | 0 | 0.00% |
Total | 44,436,235 | 100 | 49,445,976 | 100 |